Good Pharma Scorecard 2019

Good Pharma rankings for 2019 are published and Roche and Novo Nordisk, tied for the top ranking in overall transparency; each with scores of 100%. The complete list is available here.

The Good Pharma Scorecard ranks companies and new medicines on theirĀ clinical trial transparency and data-sharing performance, taking into account ethics and legal standards. The measures included in overall company transparency were as follows:

Category Measures
Data sharing applicable trials Registration by deadline
Policy provides access to analysis ready dataset and clinical study report
Policy explains how data might be requested
Company reports number and outcome of data requests
Policy specifies data will be shared by deadline
Trials in patients Registration of trial and results publicly available by 6 months after primary completion date (reported or published)
Food and Drug Administration Amendments Act trials Registration by 21 days of trial start date and results reported by 30 days after approval by FDA of indication studied

The detailed scorecard methodology is available here. For a PDF version, click here.

Leave a Reply